PAUL KOZLOWSKI, MD
Urology Physician in SEATTLE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: PAUL KOZLOWSKI, MD filed 283 Medicare Part D claims in 2023 across SEATTLE, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
PAUL KOZLOWSKI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
PAUL KOZLOWSKI, MD at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Washington
How Urology Physician compares to other specialties among Washington providers
Urology Physician share within Washington
Urology Physician is one of the more visible NUCC categories in Washington
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Urology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Urology Physician ABMS/AOA estimate
Est. board-certified rate (Urology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Urology Physician US NPIs
Specialty board-certified rate — Urology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
PAUL KOZLOWSKI, MD is a Urology Physician provider practicing in SEATTLE, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1235231200. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
PAUL KOZLOWSKI, MD appears in the CMS NPPES registry as a Urology Physician provider holding MD credentials at 1100 9TH AVE, SEATTLE, WA, 98101, with a listed phone of (206) 223-6600. NPI 1235231200 was issued on 09/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KOZLOWSKI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 283 prescription claims written by this provider, covering 89 Medicare beneficiaries and totaling roughly $16K in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1235231200 |
|---|---|
| Specialty | Urology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 09/01/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm PAUL KOZLOWSKI, MD's current license status, disciplinary history, and board certifications with the Washington State Department of Health, Medical Quality Assurance Commission in Washington before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where PAUL KOZLOWSKI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PAUL KOZLOWSKI, MD. Source: openpaymentsdata.cms.gov.
Total received
$672
Largest payer
Edap Technomed Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Washington WMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to PAUL KOZLOWSKI, MD. To verify PAUL KOZLOWSKI, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
6% brand-name claims vs 94% generic, on 283 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 712
- Total Day Supply
- 21,023
- Brand vs Generic
- 6% brand / 94% generic
- Brand Drug Cost
- $11K
- Generic Drug Cost
- $6K
- Antibiotic Claims
- 15
Patient Demographics
- Average Patient Age
- 76.1 years
- Avg HCC Risk Score
- 1.01
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 133 |
| Finasteride | 72 |
| Myrbetriq Mirabegron | 16 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 11 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How PAUL KOZLOWSKI, MD fits within the Urology Physician landscape nationally.
PAUL KOZLOWSKI, MD's 283 claims are below the specialty average of 1,280.
Nearby Urology Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as KOZLOWSKI.
Compare Urology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Washington
Frequently Asked Questions
What is PAUL KOZLOWSKI, MD's specialty? ▼
How much does PAUL KOZLOWSKI, MD prescribe under Medicare Part D? ▼
Where is PAUL KOZLOWSKI, MD located? ▼
What is PAUL KOZLOWSKI, MD's NPI number? ▼
Does PAUL KOZLOWSKI, MD prescribe more brand-name or generic drugs? ▼
How many Urology Physician providers are there in the US? ▼
What drugs does PAUL KOZLOWSKI, MD prescribe most often? ▼
Does PAUL KOZLOWSKI, MD accept Medicare? ▼
How can I verify PAUL KOZLOWSKI, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology